• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

    3/3/25 9:30:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Cohen Jon R

    (Last) (First) (Middle)
    C/O TALKSPACE, INC.
    2578 BROADWAY #607

    (Street)
    NEW YORK NY 10025

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Talkspace, Inc. [ TALK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    02/28/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/28/2025 P 75,000 A $2.86(1) 2,267,980 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.85 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    By: /s/ John C. Reilly, Attorney-in-fact for Jon R Cohen 03/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TALK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Talkspace with a new price target

    Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

    4/3/25 8:18:33 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

    KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

    12/9/24 8:34:29 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Mizuho initiated coverage on Talkspace with a new price target

    Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

    12/4/24 7:49:48 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/5/25 4:00:06 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/25 9:30:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/28/25 9:55:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    SEC Filings

    View All

    SEC Form 10-Q filed by Talkspace Inc.

    10-Q - Talkspace, Inc. (0001803901) (Filer)

    8/8/25 5:23:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Talkspace, Inc. (0001803901) (Filer)

    8/5/25 8:00:20 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SCHEDULE 13G filed by Talkspace Inc.

    SCHEDULE 13G - Talkspace, Inc. (0001803901) (Subject)

    7/29/25 2:40:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Talkspace Adopts Express Access—an AI-Powered Referral Infrastructure to Help PCPs and Employers Deliver Personalized Mental Health Care Faster Than Ever

    NEW YORK and BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Talkspace, a leading virtual behavioral health provider, and Express Access, the National Institutes of Health funded referral platform developed by Outcome Referrals, today announced a new partnership that will reshape how Americans access mental health care. Talkspace is the first national digital provider to fully adopt the Express Access TOP Match™ system at scale—integrating scientific provider matching and real-time patient progress tracking directly into its care model. Patients can now get Express Access through their employer or by scanning a free QR code offered by their primary care physician—instantly connecting them to ma

    8/12/25 8:03:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Participate in Upcoming Investor Conference

    NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the Canaccord Genuity 45th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August 12, 2025 at 1:30pm ET. A webcast link will be available on Talkspace's Investor Relations Website: https://investors.talkspace.com/. About Talkspace Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to

    8/6/25 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces Second Quarter 2025 Results

    2Q 2025 Total revenue grew 18% year-over-year to $54.3 million driven by 35% year-over-year growth in Payor revenue 2Q 2025 Net loss of $0.5 million and adjusted EBITDA1 of $2.3 million 2Q 2025 Share repurchases of $1.4 million NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company")    (NASDAQ:TALK), today reported second quarter 2025 financial results.   Three Months Ended June 30,  Six Months EndedJune 30,   2025  2024  2025  2024 Unaudited Results  % Variancefrom PriorYear  Results  % Variancefrom PriorYear (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  385.1   29%  735.1   26%Number of unique

    8/5/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Margolin Gil sold $56,227 worth of shares (19,302 units at $2.91), decreasing direct ownership by 7% to 262,616 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/17/25 9:00:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R covered exercise/tax liability with 83,978 shares, decreasing direct ownership by 3% to 2,489,082 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/12/25 9:00:05 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Technology Officer Margolin Gil covered exercise/tax liability with 12,023 shares, decreasing direct ownership by 4% to 281,918 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/12/25 9:00:08 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    View All

    Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

    New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

    9/17/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

    Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

    8/28/24 9:06:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Appoints John Mooney as Chief Product Officer

    NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

    6/5/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Financials

    Live finance-specific insights

    View All

    Talkspace Announces Second Quarter 2025 Results

    2Q 2025 Total revenue grew 18% year-over-year to $54.3 million driven by 35% year-over-year growth in Payor revenue 2Q 2025 Net loss of $0.5 million and adjusted EBITDA1 of $2.3 million 2Q 2025 Share repurchases of $1.4 million NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company")    (NASDAQ:TALK), today reported second quarter 2025 financial results.   Three Months Ended June 30,  Six Months EndedJune 30,   2025  2024  2025  2024 Unaudited Results  % Variancefrom PriorYear  Results  % Variancefrom PriorYear (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  385.1   29%  735.1   26%Number of unique

    8/5/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Report Second Quarter 2025 Results and Host Conference Call

    NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and using conference ID 8668160. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About TalkspaceTalksp

    7/21/25 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces First Quarter 2025 Results

    1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

    5/6/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/14/24 4:24:23 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/9/24 7:24:33 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

    SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

    10/5/23 6:41:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care